The European Union has implemented Article 50 of the AI Act, which imposes transparency obligations on AI providers and deployers. This regulation requires that AI interactions be clearly identified and that AI-generated content is marked to distinguish it from human-created material. The aim is to address concerns about manipulation and fraud, ensuring that consumers are aware when they are interacting with AI systems. This move is part of the EU's broader effort to regulate AI technologies and protect consumers from potential deception.
Read originalStanford's Evo 2 AI model has made a significant leap in synthetic biology by generating phages that effectively target E. coli. This breakthrough demonstrates the potential of AI to design entire viral genomes, moving beyond simple DNA edits. The model produced thousands of candidate genomes, with 16 showing strong E. coli-killing activity in lab tests. By releasing Evo 2 as open-source software, Stanford is inviting further exploration and innovation in genome design, potentially paving the way for new treatments against resistant bacteria like MRSA.
Alibaba is testing a new business model for its upcoming Qwen open-weight AI model, introducing revenue-sharing terms for commercial users. This move targets larger companies that profit from offering the model as a service, requiring them to enter a commercial agreement with Alibaba. The approach mirrors the licensing model used by Moonshot for its Kimi K3 model, which includes revenue-sharing for companies exceeding certain revenue thresholds. This shift signifies Alibaba's strategy to monetize its open-weight models while maintaining their open-source nature, potentially setting a precedent for other AI developers.